Description

Tadalafil and Sildenafil Troches offer a unique, mucosal delivery system for two well-established PDE5 inhibitors used in the treatment of erectile dysfunction (ED) and sexual performance support. By combining tadalafil and sildenafil into a single compounded troche, this formulation offers both rapid onset and extended duration of action—supporting enhanced blood flow, improved erectile quality, and greater flexibility in timing intimacy.

Sildenafil is fast-acting, typically working within 30–60 minutes and lasting about 4–6 hours. It’s ideal for patients who want on-demand performance support with predictable onset. It increases nitric oxide–mediated vasodilation in penile tissue, facilitating erection in response to sexual stimulation. Tadalafil, on the other hand, has a slower onset (1–2 hours) but a significantly longer half-life—lasting up to 36 hours. It’s often preferred for patients seeking more spontaneous sexual activity or for managing conditions like penile rehabilitation or benign prostatic hyperplasia (BPH).

When used together in troche form, tadalafil and sildenafil can complement each other, providing both immediate support and extended coverage, while the buccal delivery route allows for enhanced mucosal absorption, bypassing the gastrointestinal tract and potentially reducing systemic side effects such as headache or flushing.

Key Benefits of Sildenafil/Tadalafil

• Rapid onset with local absorption: Troche form bypasses GI and first-pass metabolism, often with faster onset.
• Improved erectile function: Enhances rigidity, duration, and satisfaction of erections.
• Boosts confidence and intimacy: Reduces anxiety associated with performance.
• Flexible dosing options: Tadalafil is better for spontaneity and daily use; sildenafil works well for planned intimacy.
• Possible urinary and prostate benefits (Tadalafil): May improve LUTS (lower urinary tract symptoms) in BPH.
• May enhance orgasmic quality (both genders): Through increased genital blood flow and neural response.